SARS-CoV-2 reinfections and long COVID in the post-omicron phase of the pandemic
We are reviewing the current state of knowledge on the virological and immunological
correlates of long COVID, focusing on recent evidence for the possible association between …
correlates of long COVID, focusing on recent evidence for the possible association between …
Challenges and opportunities in long COVID research
RE Hamlin, CA Blish - Immunity, 2024 - cell.com
Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-
CoV-2 infection but rather have persistent or new symptoms for months to years following …
CoV-2 infection but rather have persistent or new symptoms for months to years following …
[HTML][HTML] Trends in laboratory-confirmed SARS-CoV-2 reinfections and associated hospitalizations and deaths among adults aged≥ 18 years—18 US jurisdictions …
KC Ma - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
During September 2021–December 2022, the percentages of reinfections among all COVID-
19 cases, hospitalizations, and deaths reported by 18 US jurisdictions increased …
19 cases, hospitalizations, and deaths reported by 18 US jurisdictions increased …
Reengineering a machine learning phenotype to adapt to the changing COVID-19 landscape: A study from the N3C and RECOVER consortia
Background In 2021, we used the National COVID Cohort Collaborative (N3C) as part of the
NIH RECOVER Initiative to develop a machine learning (ML) pipeline to identify patients …
NIH RECOVER Initiative to develop a machine learning (ML) pipeline to identify patients …
[PDF][PDF] What are the clinical-epidemiological differences between initial infection and reinfection COVID-19 with fourth dose of bivalent mRNA vaccine? A Study in the …
JL Turabian - J Inf Dis Trav Med, 2024 - researchgate.net
Background: The clinical-epidemiological differences between primary infections versus
reinfections of covid-19 with the 4th dose of bivalent mRNA vaccine are not known …
reinfections of covid-19 with the 4th dose of bivalent mRNA vaccine are not known …
Evidence base for Health Care strategies to protect vulnerable patients during the COVID-19 pandemic—reply
In Reply People with cancer experience an increased risk of SARS-CoV-2 vaccine
nonresponse and infection, treatment delays from active infection, COVID-19 hospitalization …
nonresponse and infection, treatment delays from active infection, COVID-19 hospitalization …
Optimal COVID-19 vaccine prioritization by age depends critically on inter-group contacts and vaccination rates
I Atienza-Diez, G Rodriguez-Maroto… - Royal Society …, 2024 - royalsocietypublishing.org
The limited availability of COVID-19 vaccines has prompted extensive research on optimal
vaccination strategies. Previous studies have considered various non-pharmaceutical …
vaccination strategies. Previous studies have considered various non-pharmaceutical …
Unraveling the fear of COVID-19 reinfection: insights from frontline doctors in China
B Zhang, S **ong, Y Sun, C **ang… - Psychology, Health & …, 2024 - Taylor & Francis
Considering the end of global emergency status of Coronavirus-19 (COVID-19) and the
persistent risk of reinfection for healthcare workers (HCWs), it is important to evaluate the …
persistent risk of reinfection for healthcare workers (HCWs), it is important to evaluate the …
[HTML][HTML] 新型冠状病毒重复感染流行病学研究进展
廖春晓， 王波， 吕筠， **立明 - 中华流行病学杂志, 2023 - html.rhhz.net
新型冠状病毒Omicron 变异株持续突变演化, 新亚型免疫逃逸能力不断增**, 重复感染风险增加,
且两次感染时间间隔可能缩短. 与初始感染相比, 尽管重复感染的临床表现较轻 …
且两次感染时间间隔可能缩短. 与初始感染相比, 尽管重复感染的临床表现较轻 …
Post-acute sequelae of hospitalised COVID-19 re-infection compared with hospitalised first-time infection: a population-based retrospective cohort study in Hong Kong
Introduction COVID-19 infection is associated with post-acute adverse outcomes affecting
multiple organ systems. Although preliminary studies have suggested that COVID-19 re …
multiple organ systems. Although preliminary studies have suggested that COVID-19 re …